Provided by Tiger Trade Technology Pte. Ltd.

3D MEDICINES

2.805
-0.030-1.06%
Volume:71.00K
Turnover:201.08K
Market Cap:723.69M
PE:-3.90
High:2.890
Open:2.890
Low:2.825
Close:2.835
52wk High:8.240
52wk Low:1.820
Shares:258.00M
HK Float Shares:258.00M
Volume Ratio:1.52
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.720
ROE:-32.79%
ROA:-11.04%
PB:1.18
PE(LYR):-3.90
PS:1.73

Loading ...

3D Medicines Reports 1H 2026 Results: Revenue Steady at RMB 210.52 Million, Net Loss Narrows; Envafolimab Sales Up 43% Sequentially

Bulletin Express
·
Yesterday

Hong Kong Stock Movers: mRNA Concept Stocks Lead Gains, CanSinoBIO (06185) Surges Over 17% as Moderna's mRNA Neoantigen Therapy Set to Debut at ESMO Congress

Stock News
·
Yesterday

3D Medicines Extends HK$50.00 Million Note with Mega Link to 2028 at 9% Coupon

Bulletin Express
·
Sep 17

3D Medicines FY26 H1 Comprehensive Loss Narrows 4.47% to RMB 88.5 Million; Revenue Rises 0.6% to RMB 210.5 Million

Reuters
·
Aug 31

3D Medicines Shifts Cayman Registered Office to Harbour Place, Effective 16 June 2026

Bulletin Express
·
Aug 28

Hong Kong Stocks Close Higher: Vaccine Sector Surges on Historic mRNA Cancer Trial Breakthrough, Gold Miners Rally Again

Stock News
·
Aug 20

3D Medicines Surges Over 55% Pre-Noon, Focusing on Cutting-Edge Global Oncology Advancements

Deep News
·
Aug 20

HK Movers | Pharma Stocks Surge With 3D Medicines up 68%, CanSino Biologics up 52%

Tiger Newspress
·
Aug 20

Biotech Sector Surges as Moderna's Melanoma Vaccine Milestone Sparks Oncology and mRNA Repricing

Stock News
·
Aug 20

Global First mRNA Cancer Vaccine Hits Major Milestone, 3D Medicines Jumps 17% on International Revaluation

Stock News
·
Aug 19

3D Medicines Says Arbitration Award From Sellas Life Sciences Fully Settled

MT Newswires Live
·
Aug 18

3D MEDICINES (01244) Confirms Full Receipt of HK$7.983 Million in Arbitration Cost Recovery from SELLAS

Stock News
·
Aug 18

3D Medicines Recovers HK$7.98 Million in Arbitration with SELLAS; 3D189 Trial Reaches 78 of 80 Target Events

Bulletin Express
·
Aug 18

3D Medicines - Arbitrator Dismisses All Sellas Claims; Orders Sellas to Pay HK$8 Mln in Costs

THOMSON REUTERS
·
Aug 18

3D Medicines Sets 31 Aug 2026 Board Meeting to Review H1 2026 Results and Potential Interim Dividend

Bulletin Express
·
Aug 17

3D Medicines Schedules Board Meeting to Review Interim Results, Consider Dividend

Reuters
·
Aug 17

3D Medicines Announces Non-Executive Board Transition: Zhu Jinqiao to Retire, Zhang Wenhua Named Successor

Bulletin Express
·
Aug 07

3D Medicines Files Board, Board Committee Member List with Disclosure Roles

Reuters
·
Aug 07

3D Medicines Appoints Ms. Zhang Wenhua as New Non-Executive Director

Stock News
·
Aug 07

3D Medicines Maintains Stable Share Base in July 2026; Public Float Meets HKEX Requirements

Bulletin Express
·
Aug 06